Surname of first author EBRT EBRT EBRT ICR ICR ICR Concurrent chemotherapy
Type
Total dose Median(range) Fraction (Gy) Fraction (Gy)
Number
Number
Type
Yilmaz 3D-CRT 50.4 1.8 6 6 5 Weekly 40mg/ m2 cisplatin
Yildirim 3D-CRT 50.4 1.8 7 7 4 Weekly 40mg/ m2 cisplatin
Cima 3D-CRT NS NS NS NS NS Weekly 40mg/ m2 cisplatin
Guler 3D-CRT 50.4 1.8 7 7 4 Weekly 40mg/ m2 cisplatin
Lucia 3D-CRT/IMRT 45-50.4 NS 7 7 3–4 Weekly 40mg/ m2 cisplatin
Hong
NS
54
2
3.5
3.5
8
Weekly 30mg/ m2 cisplatin or triweekly paclitaxel 135mg/m2 and carboplatin
Herrera IGRT 45(45-50.4) NS 7 7 3–4 Weekly 40mg/ m2 cisplatin(89.4%)
Chong (2015)
3D-CRT
45
1.8
-
-
-
Weekly 40mg/ m2 cisplatin
Onal 3D-CRT 50.4 1.8 7 7 4 Weekly 40mg/ m2 cisplatin
Im NS NS NS NS NS NS Weekly cisplatin
Onal 3D-CRT 50.4 1.8 7 7 4 Weekly 40mg/ m2 cisplatin
Chong (2017)
3D-CRT
45
1.8
6
6
NS
Weekly 40mg/ m2 cisplatin
Lee 3D-CRT 45 1.8 NS NS NS Weekly 40mg/ m2 cisplatin
Vercellino NS NS NS NS NS NS NS NS